Mustafa Kuzeytemiz

Dr. Mustafa Kuzeytemiz


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in The Eurasian Journal of Medicine
Verified
Journal Article
Open access
ETERHAN TENEKECIOGLU
ERHAN TENEKECIOGLU
OOOzlem Ozluk
Ozlem Ozluk
MKMustafa Kuzeytemiz
Mustafa Kuzeytemiz
DTDursun Topal
Dursun Topal
MYMustafa Yilmaz
Mustafa Yilmaz
FVFahriye Vatansever
Fahriye Vatansever
Objective: Non-dipper hypertension is associated with increased cardiovascular morbidity and mortality. The purpose of this study was to evaluate the association of non-dipping hypertension with aortic diameter in patients with metabolic syndrome. Materials and Methods: This study included 70 hypertensive patients with metabolic syndrome. These patients were evaluated with 24-h blood pressure Holter monitoring and divided into two groups of 35 patients each. Aortic diameter was measured by M-mode and two-dimensional echocardiography. These parameters were compared between the two groups. Results: In the dipper group, there were 26 female and 9 male patients with a mean age of 55±11 years. In the non-dipper group, there were 25 female and 10 male patients with a mean age of 56±11 years. No significant difference was found between the two groups in terms of basic characteristics. Non-dipper hypertensive patients had a higher thoracic aortic diameter value than dipper patients (35.6±2.4 and 33.23±1.1, p<0.01). Conclusion: These findings suggest that thoracic aortic diameter value is higher in patients with non-dipper hypertension.

5 January 2022 in Journal of Investigative Medicine
Verified
Journal Article
Open access
PDF file
MKMustafa Kuzeytemiz
Mustafa Kuzeytemiz
ETErhan Tenekecioglu
Erhan Tenekecioglu
Hypertension is found frequently in patients with COVID-19 and is often treated with ACE inhibitors (ACEIs) and angiotensin receptor blockers (ARBs). SARS-CoV-2, the pathogen of COVID-19, binds to the receptors of ACE2 to enter the alveolar cells, raising questions on whether these drugs are salutary or harmful with respect to any propensity for COVID-19 or to disease prognosis. We investigated the impact of ACEI/ARB and the clinical prognosis of patients with hypertension with COVID-19. In this study, 250 patients with hypertension (<45 years old) with COVID-19 were recruited. None of these patients had any chronic disease except for hypertension. The study population was grouped according to antihypertensive medication: ACEI/ARB user and non-ACEI/ARB user. Patients were followed for clinical prognosis and biochemical and radiological findings during their hospital stay. Adverse cardiovascular event (myocardial infarction, all-cause death, stroke), transfer to the intensive care unit, severity of symptoms during the treatment course, length of hospital stay and effort capacity in the treadmill stress test were recorded. During hospital stay, there was no significant difference in terms of length of hospital stay, medication for COVID-19, left ventricular ejection fraction on echocardiography and metabolic equivalents in the treadmill stress test between patients treated with and without ACEI/ARB. During treatment of COVID-19, there was no significant difference in clinical adverse event, effort capacity and clinical course between patients with and without ACEI/ARB. It appears that patients with COVID-19 may continue to use ACEI/ARB or that ACEI/ARB may be added safely to their antihypertensive treatment.

30 June 2022 in TURKISH JOURNAL of CLINICS and LABORATORY
Verified
Journal Article
Open access
PDF file
MKMustafa Kuzeytemiz
Mustafa Kuzeytemiz
BKBilgen Bi̇çer Kanat
Bilgen Bi̇çer Kanat
Aim: Hypertension (HT) is a very important risk factor for cerebrovascular, renal and various vascular diseases, especially cardiovascular diseases. It is seen in almost 1/3 of the adult world population and its incidence is gradually increasing. 95% of HT is essential and various reasons are emphasized in the etiology. Conditions that cause psychological stress, especially depression; Although the relationship between them is not clear, it was seen as a risk factor for HT. Because they will live with HT for a long time, early diagnosis and treatment is important, especially in young patients. Predisposing factors should also be taken into account in treatment. Anxiety and depression, which are called increased sympathetic activity in young people, can be a trigger for HT. In this study, we wanted to investigate the susceptibility to depressionanxiety in newly diagnosed young hypertensive patients. According to the result, we thought that we could make new recommendations in the treatment of HT. Materials and Methods: 175 patients under the age of 45 with newly diagnosed HT and 125 individuals under 45 without any health problems were included in the study. Those diagnosed with HT with secondary reasons and those with chronic diseases such as coronary artery disease (CAD), diabetes mellitus (DM), chronic renal failure (CRF), congestive heart failure (CHF) were excluded from the study. Testing was performed with the Hospital Depression Anxiety Scale (HDAS). In this test for both anxiety and depression; 0-7 points were considered normal, 8-10 points were considered borderline, and over 11 points were considered abnormal. Results: When the results were evaluated, there was no difference between the groups in terms of age, gender, and routine biochemical tests. Both depression and anxiety scales were found to be significantly higher in the HT group. In young hypertensive patients, we have seen that HT and depression-anxiety frequently coexist. Conclusion: In this case, we should definitely examine the psychological stress states of young patients we diagnosed with HT. It would be appropriate to refer patients who we think may have depression and anxiety for psychological support and treatment. When psychological problems are treated, HT may improve without the need for antihypertensive treatment. Thus, we can develop new approaches in HT treatment.

17 October 2022 in Kocatepe Tıp Dergisi
Verified
Journal Article
Closed access
PDF file
MKMustafa Kuzeytemiz
Mustafa Kuzeytemiz
OBJECTIVE: The recent coronavirus disease 2019 (COVID-19) outbreak has become a worldwide public health problem. Hypertension, diabetes mellitus, obesity, chronic heart and lung diseases increase the risk of development of COVID-19 infection and severe COVID-19 disease. In this study; we aimed to investigate whether hyperlipidemia alone increases the risk of development of COVID-19 infection.MATERIAL AND METHODS: One hundred-thirty four patients who were hospitalized with the diagnosis of COVID-19 and did not have any chronic disease and one hundred-twenty-two healthy controls were included in this study. The average of the lipid values of the patient group in the last 6 months before admission was calculated. Likewise, the average of the lipid parameters of the control group in the last 6 months was taken.RESULTS: There were no differences between two groups with regard to age, gender, and laboratory characteristics. Triglyceride and Low-density lipoprotein cholesterol values were significantly higher and High-density lipoprotein cholesterol levels were significantly lower in the COVID-19 patients compared to the control subjects (p < 0.01).CONCLUSIONS: Although research on the association of dyslipidemia with COVID-19 is still insufficient, our findings show that serum cholesterol levels are significantly associated with the risk of COVID-19 infection.

3 September 2022 in The European Research Journal
Verified
Journal Article
Open access
PDF file
HÇHakan Çakır
Hakan Çakır
CTCüneyt Toprak
Cüneyt Toprak
AKAli Karagoz
Ali Karagoz
SUSamet Uysal
Samet Uysal
NHNuri Havan
Nuri Havan
MDMehmet Demi̇r
Mehmet Demi̇r
Objectives: Platelet-lymphocyte ratio (PLR) combines the predictive risk of platelet and lymphocyte counts into a single risk index. PLR has been studied as a predictive marker in a variety of cardiovascular diseases. However, our understanding of the link between PLR and coronary artery disease (CAD) remains limited. The present study aimed to evaluate the relationship between PLR and intensity of coronary atherosclerosis in patients with suspected CAD. Methods: In this retrospective study, we included 221 patients undergoing dual-source 64-slice coronary computed tomography angiography (CCTA). Total and different types of leukocyte counts were measured with an automatic blood counter. Based on a modified version of the American Heart Association's categorisation, the coronary artery tree was divided into 16 segments. To assess the extent of coronary atherosclerosis, the number of affected coronary segments was counted. Coronary artery plaques were classified into three categories: (1) calcified plaque, (2) non-calcified plaque, and (3) mixed plaque. Results: After multivariable backward stepwise regression analysis, PLR remained as an independent predictor for both the presence and extent of coronary atherosclerosis (OR=2.38, 95% CI: 1.27-4.47 and OR=1.66, 95% CI: 1.10-2.51, respectively). There was no significant relationship between PLR and plaque morphology. Conclusions: Higher PLR was associated with the intensity of coronary atherosclerosis detected by CCTA. Further research is necessary to determine the optimal approach to using PLR in medical practice.

3 January 2024 in The European Research Journal
Verified
Journal Article
Open access
PDF file
NKNurcan KAT
Nurcan KAT
NSNazife Nur Özer Sensoy
Nazife Nur Özer Sensoy
MKMustafa Kuzeytemiz
Mustafa Kuzeytemiz
ÖDÖmer Furkan Demir
Ömer Furkan Demir
Objectives: Pulmonary embolism (PE) is an important disease due to its mortality and morbidity-related clinical conditions. Patients with a high risk of death within 30 days are discriminated against with the help of various clinical scores. Non-alcoholic fatty liver disease (NAFLD) has been found to be associated with atherosclerosis. We aimed to investigate the effect of NAFLD on disease severity and early death rate in patients with pulmonary embolism. Methods: This retrospective study includes patients who applied to the emergency department with suspected pulmonary embolism and whose diagnosis was confirmed according to the results of the examination. In addition to confirming the diagnosis of PE, hepatic steatosis was detected and graded by tomographic examination of the liver and spleen. Disease severity was stratified by Simplified Pulmonary Embolism Severity Index (sPESI). Results: A total of 165 patients (105 with sPESI≥1 and 60 with sPESI<1 controls) were included. The rate of mortality was 12% (n=13) in the sPESI≥1 group. The prevalence of NAFLD was 64% and the prevalence of hepatosteatosis was similar according to disease severity and prognosis (67% vs. 58%; P=0.28 and 69% vs. 63%; P=0.77). Besides the effect of disease severity; chronic lung disease (CLD) and chronic kidney disease (CKD) were independently associated with poor prognosis by multivariate analysis [3.71 (1.02-13.46); P=0.04 and 15.89 (2.57-98.35); P=0.003]. Conclusion: No association between disease severity and prognosis was observed with NAFLD in acute PE disease.